Boule Diagnostics AB Stock

Equities

BOUL

SE0011231158

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 07:15:04 2024-04-17 am EDT 5-day change 1st Jan Change
9.56 SEK -0.21% Intraday chart for Boule Diagnostics AB +0.84% -14.80%
Sales 2023 571M 52.22M Sales 2024 * 580M 53M Capitalization 371M 33.94M
Net income 2023 25M 2.29M Net income 2024 * 28M 2.56M EV / Sales 2023 0.87 x
Net Debt 2023 60.2M 5.5M Net Debt 2024 * 77.93M 7.12M EV / Sales 2024 * 0.77 x
P/E ratio 2023
17.5 x
P/E ratio 2024 *
12.9 x
Employees 200
Yield 2023 *
2.04%
Yield 2024 *
2.14%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.21%
1 week+0.84%
Current month-3.73%
1 month-4.78%
3 months-13.25%
6 months-1.34%
Current year-14.80%
More quotes
1 week
9.18
Extreme 9.18
9.76
1 month
9.14
Extreme 9.14
10.50
Current year
9.05
Extreme 9.05
12.62
1 year
8.66
Extreme 8.66
12.78
3 years
8.66
Extreme 8.66
69.70
5 years
8.66
Extreme 8.66
79.60
10 years
8.66
Extreme 8.66
108.88
More quotes
Managers TitleAgeSince
Director of Finance/CFO - Dec. 31
Sales & Marketing - 21-09-30
Human Resources Officer - 22-09-30
Members of the board TitleAgeSince
Director/Board Member 63 15-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
More insiders
Date Price Change Volume
24-04-17 9.56 -0.21% 1,013
24-04-16 9.58 +1.48% 20,871
24-04-15 9.44 -0.42% 4,404
24-04-12 9.48 -0.84% 6,092
24-04-11 9.56 +0.84% 8,362

Delayed Quote Nasdaq Stockholm, April 17, 2024 at 07:15 am EDT

More quotes
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.56 SEK
Average target price
10.4 SEK
Spread / Average Target
+8.79%
Consensus